Results 31 to 40 of about 167,106 (231)

Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT2A and ampa in the medial prefrontal cortex (MPFC)

open access: yesEuropean Psychiatry, 2021
Introduction Autism Spectrum Disorder and Social Anxiety Disorder are mental illnesses characterized by a dysfunction in social behavior (SB); a phenomenon largely mediated by the medial prefrontal cortex (mPFC). Clinical studies have demonstrated that
A. Markopoulos   +3 more
doaj   +1 more source

Neuronal localization of the 5-HT2 receptor family in the amygdaloid complex

open access: yesFrontiers in Pharmacology, 2014
The amygdaloid complex (or amygdala), a heterogeneous structure located in the medial portion of the temporal lobe, is composed of deep, superficial, and remaining nuclei.
Cristiano eBombardi
doaj   +1 more source

Serotonin 2A (5-HT2A) receptor affects cell–matrix adhesion and the formation and maintenance of stress fibers in HEK293 cells

open access: yesScientific Reports, 2020
5-HT2A, a G-protein coupled receptor, is widely expressed in the human body, including in the gastrointestinal tract, platelets and the nervous system. It mediates various functions, for e.g.
Joe Anand Kumar John Jayakumar   +2 more
doaj   +1 more source

Role of 5-HT2A receptor antagonists in the treatment of insomnia

open access: yesNature and Science of Sleep, 2010
Insomnia encompasses a difficulty in falling asleep (sleep-onset insomnia) and/or a difficulty in staying asleep (SMI). Several selective serotonin-2A (5-HT2A) receptor antagonists have been in development as potential treatments for SMI. However, none have shown a sufficiently robust benefit-to-risk ratio, and none have reached market approval.
Kimberly E, Vanover, Robert E, Davis
openaire   +3 more sources

The T102C Polymorphism of the 5-HT2A-Receptor Gene in Fibromyalgia

open access: yesNeurobiology of Disease, 1999
Based on a possible involvement of serotonergic dysfunction in the pathophysiology of fibromyalgia (FM) and on preliminary reports of a possible genetically driven vulnerability for this disorder we investigated the silent T102C polymorphism of the 5-HT2A-receptor gene in 168 FM patients and 115 healthy controls.
Brigitta Bondy   +11 more
openaire   +3 more sources

Discovery and Structure-Based Optimization of 6-Bromotryptamine Derivatives as Potential 5-HT2A Receptor Antagonists

open access: yesMolecules, 2015
5-Hydroxytryptamine type 2A (5-HT2A) receptor is an important target for developing innovative antipsychotic agents in neuropsychiatric disorder therapies.
Lijian Ding   +8 more
doaj   +1 more source

Regulation of 5-HT2A receptor mRNA in P11 cells

open access: yesBehavioural Brain Research, 1995
P11 cells were used as an in vitro model system to explore effects of exposure to 5-HT on levels of mRNA encoding 5-HT2A receptors. Exposure of cells to the agonist 5-HT resulted in a doubling of receptor mRNA levels. mRNA levels returned to control levels within 8-16 h.
R C, Ferry, P B, Molinoff
openaire   +2 more sources

Enhanced effect of the hallucinogen DOI in L-DOPA receptor Gpr143-deficient mice

open access: yesJournal of Pharmacological Sciences
Hallucinogens, such as lysergic acid diethylamide, act primarily through the 5-hydroxytryptamine 2A (5-HT2A) receptor, but their regulatory mechanisms remain unclear.
Daiki Masukawa   +5 more
doaj   +1 more source

Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT2A receptor

open access: yes, 2020
The 5-HT2A receptor is a target for hallucinogenic and non-hallucinogenic ligands that evoke unique behavioral, electrophysiological and molecular consequences.
Vaidya, Vidita A., Banerjee, Antara A.
core   +1 more source

Citrus aurantium honey‐mediated gut homeostasis and anti‐inflammation via Thorl/Nprl2‐TORC1 signaling: Network pharmacology and Drosophila validation

open access: yesAnimal Models and Experimental Medicine, EarlyView.
The study employed a four‐tiered strategy: (1) UHPLC‐FTMS profiling of Citrus aurantium honey to characterize its chemical composition; (2) network pharmacology analysis integrating target prediction, protein–protein interaction networks, and KEGG pathway enrichment to identify the Thor1/Nprl2‐TORC1 axis as a key mechanistic pathway; (3) in vitro ...
Wenqi Wan   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy